v3.19.3

Valuation (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2019
Fair Value Disclosures [Abstract] |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] | The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments that are measured at fair value on a recurring basis as of September 30, 2019:
Description |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
|  | (In thousands)
Assets: |  |  |  |  |  |  |  |
Securities, at fair value: |  |  |  |  |  |  |  |
Agency RMBS |  | $ | — |  |  | $ | 1,541,508 |  |  | $ | 23,499 |  |  | $ | 1,565,007 |
Non-Agency RMBS |  | — |  |  | 75,732 |  |  | 81,482 |  |  | 157,214 |
CMBS |  | — |  |  | 27,206 |  |  | 12,368 |  |  | 39,574 |
CLOs |  | — |  |  | 39,392 |  |  | 28,008 |  |  | 67,400 |
Asset-backed securities, backed by consumer loans |  | — |  |  | — |  |  | 39,316 |  |  | 39,316 |
Corporate debt securities |  | — |  |  | — |  |  | 3,182 |  |  | 3,182 |
Corporate equity securities |  | 1,958 |  |  | — |  |  | 2,278 |  |  | 4,236 |
Loans, at fair value: |  |  |  |  |  |  |  |
Residential mortgage loans |  | — |  |  | — |  |  | 797,728 |  |  | 797,728 |
Commercial mortgage loans |  | — |  |  | — |  |  | 260,626 |  |  | 260,626 |
Consumer loans |  | — |  |  | — |  |  | 151,699 |  |  | 151,699 |
Corporate loans |  | — |  |  | — |  |  | 15,790 |  |  | 15,790 |
Investment in unconsolidated entities, at fair value |  | — |  |  | — |  |  | 70,435 |  |  | 70,435 |
Financial derivatives–assets, at fair value: |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities |  | — |  |  | — |  |  | 1,078 |  |  | 1,078 |
Credit default swaps on asset-backed indices |  | — |  |  | 2,146 |  |  | — |  |  | 2,146 |
Credit default swaps on corporate bonds |  | — |  |  | 41 |  |  | — |  |  | 41 |
Credit default swaps on corporate bond indices |  | — |  |  | 5,060 |  |  | — |  |  | 5,060 |
Interest rate swaps |  | — |  |  | 3,440 |  |  | — |  |  | 3,440 |
TBAs |  | — |  |  | 142 |  |  | — |  |  | 142 |
Total return swaps |  | — |  |  | — |  |  | 235 |  |  | 235 |
Futures |  | 484 |  |  | — |  |  | — |  |  | 484 |
Forwards |  | — |  |  | 114 |  |  | — |  |  | 114 |
Total assets |  | $ | 2,442 |  |  | $ | 1,694,781 |  |  | $ | 1,487,724 |  |  | $ | 3,184,947 |
Liabilities: |  |  |  |  |  |  |  |
Securities sold short, at fair value: |  |  |  |  |  |  |  |
Government debt |  | $ | — |  |  | $ | (36,436 | ) |  | $ | — |  |  | $ | (36,436 | )
Corporate debt securities |  | — |  |  | (473 | ) |  | — |  |  | (473 | )
Financial derivatives–liabilities, at fair value: |  |  |  |  |  |  |  |
Credit default swaps on asset-backed indices |  | — |  |  | (194 | ) |  | — |  |  | (194 | )
Credit default swaps on corporate bonds |  | — |  |  | (186 | ) |  | — |  |  | (186 | )
Credit default swaps on corporate bond indices |  | — |  |  | (11,185 | ) |  | — |  |  | (11,185 | )
Interest rate swaps |  | — |  |  | (12,115 | ) |  | — |  |  | (12,115 | )
TBAs |  | — |  |  | (904 | ) |  | — |  |  | (904 | )
Futures |  | (67 | ) |  | — |  |  | — |  |  | (67 | )
Total return swaps |  | — |  |  | (707 | ) |  | (214 | ) |  | (921 | )
Other secured borrowings, at fair value |  | — |  |  | — |  |  | (438,629 | ) |  | (438,629 | )
Total liabilities |  | $ | (67 | ) |  | $ | (62,200 | ) |  | $ | (438,843 | ) |  | $ | (501,110 | )
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2018:
Description |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
|  | (In thousands)
Assets: |  |  |  |  |  |  |  |
Cash equivalents |  | $ | 12,460 |  |  | $ | — |  |  | $ | — |  |  | $ | 12,460 |
Investments, at fair value- |  |  |  |  |  |  |  |
Agency residential mortgage-backed securities |  | $ | — |  |  | $ | 1,442,924 |  |  | $ | 7,293 |  |  | $ | 1,450,217 |
U.S. Treasury securities |  | — |  |  | 76 |  |  | — |  |  | 76 |
Private label residential mortgage-backed securities |  | — |  |  | 211,348 |  |  | 91,291 |  |  | 302,639 |
Private label commercial mortgage-backed securities |  | — |  |  | 33,105 |  |  | 803 |  |  | 33,908 |
Commercial mortgage loans |  | — |  |  | — |  |  | 211,185 |  |  | 211,185 |
Residential mortgage loans |  | — |  |  | — |  |  | 496,830 |  |  | 496,830 |
Collateralized loan obligations |  | — |  |  | 108,978 |  |  | 14,915 |  |  | 123,893 |
Consumer loans and asset-backed securities backed by consumer loans |  | — |  |  | — |  |  | 206,761 |  |  | 206,761 |
Corporate debt |  | — |  |  | 16,074 |  |  | 6,318 |  |  | 22,392 |
Secured notes |  | — |  |  | — |  |  | 10,917 |  |  | 10,917 |
Real estate owned |  | — |  |  | — |  |  | 34,500 |  |  | 34,500 |
Common stock |  | 2,200 |  |  | — |  |  | — |  |  | 2,200 |
Corporate equity investments |  | — |  |  | — |  |  | 43,793 |  |  | 43,793 |
Total investments, at fair value |  | 2,200 |  |  | 1,812,505 |  |  | 1,124,606 |  |  | 2,939,311 |
Financial derivatives–assets, at fair value- |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities |  | — |  |  | — |  |  | 1,472 |  |  | 1,472 |
Credit default swaps on corporate bond indices |  | — |  |  | 733 |  |  | — |  |  | 733 |
Credit default swaps on corporate bonds |  | — |  |  | 2,473 |  |  | — |  |  | 2,473 |
Credit default swaps on asset-backed indices |  | — |  |  | 8,092 |  |  | — |  |  | 8,092 |
Total return swaps |  | — |  |  | 1 |  |  | — |  |  | 1 |
Interest rate swaps |  | — |  |  | 7,224 |  |  | — |  |  | 7,224 |
Forwards |  | — |  |  | 6 |  |  | — |  |  | 6 |
Total financial derivatives–assets, at fair value |  | — |  |  | 18,529 |  |  | 1,472 |  |  | 20,001 |
Repurchase agreements, at fair value |  | — |  |  | 61,274 |  |  | — |  |  | 61,274 |
Total investments, financial derivatives–assets, and repurchase agreements, at fair value |  | $ | 2,200 |  |  | $ | 1,892,308 |  |  | $ | 1,126,078 |  |  | $ | 3,020,586 |
Liabilities: |  |  |  |  |  |  |  |
Investments sold short, at fair value- |  |  |  |  |  |  |  |
Agency residential mortgage-backed securities |  | $ | — |  |  | $ | (772,964 | ) |  | $ | — |  |  | $ | (772,964 | )
Government debt |  | — |  |  | (54,151 | ) |  | — |  |  | (54,151 | )
Corporate debt |  | — |  |  | (6,529 | ) |  | — |  |  | (6,529 | )
Common stock |  | (16,933 | ) |  | — |  |  | — |  |  | (16,933 | )
Total investments sold short, at fair value |  | (16,933 | ) |  | (833,644 | ) |  | — |  |  | (850,577 | )
Description |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
(continued) |  | (In thousands)
Financial derivatives–liabilities, at fair value- |  |  |  |  |  |  |  |
Credit default swaps on corporate bond indices |  | $ | — |  |  | $ | (11,557 | ) |  | $ | — |  |  | $ | (11,557 | )
Credit default swaps on corporate bonds |  | — |  |  | (3,246 | ) |  | — |  |  | (3,246 | )
Credit default swaps on asset-backed indices |  | — |  |  | (2,125 | ) |  | — |  |  | (2,125 | )
Interest rate swaps |  | — |  |  | (3,397 | ) |  | — |  |  | (3,397 | )
Total return swaps |  | — |  |  | (6 | ) |  | — |  |  | (6 | )
Futures |  | (355 | ) |  | — |  |  | — |  |  | (355 | )
Forwards |  | — |  |  | (120 | ) |  | — |  |  | (120 | )
Total financial derivatives–liabilities, at fair value |  | (355 | ) |  | (20,451 | ) |  | — |  |  | (20,806 | )
Other secured borrowings, at fair value |  | — |  |  | — |  |  | (297,948 | ) |  | (297,948 | )
Total investments sold short, financial derivatives–liabilities, and other secured borrowings, at fair value |  | $ | (17,288 | ) |  | $ | (854,095 | ) |  | $ | (297,948 | ) |  | $ | (1,169,331 | )
Schedule of Financial Instruments | The following table summarizes the estimated fair value of all other financial instruments not measured at fair value on a recurring basis as of September 30, 2019:
(In thousands) |  | Fair Value |  | Carrying Value
Other financial instruments |  |  |  |
Assets: |  |  |  |
Cash and cash equivalents |  | $ | 33,251 |  |  | $ | 33,251 |
Restricted cash |  | 175 |  |  | 175 |
Due from brokers |  | 66,162 |  |  | 66,162 |
Reverse repurchase agreements |  | 36,473 |  |  | 36,473 |
Liabilities: |  |  |  |
Repurchase agreements |  | 2,056,422 |  |  | 2,056,422 |
Other secured borrowings |  | 91,151 |  |  | 91,151 |
Senior notes, net |  | 86,952 |  |  | 85,232 |
Due to brokers |  | 5,978 |  |  | 5,978 |
Cash and cash equivalents includes cash held in an interest bearing overnight account, for which fair value equals the carrying value, and cash held in money market accounts, which are liquid in nature and for which fair value equals the carrying value; such assets are considered Level 1. Restricted cash includes cash held in a segregated account for which fair value equals the carrying value; such assets are considered Level 1. Due from brokers and Due to brokers include collateral transferred to or received from counterparties, along with receivables and payables for open and/or closed derivative positions. These receivables and payables are short term in nature and any collateral transferred consists primarily of cash; fair value of these items is approximated by carrying value and such items are considered Level 1. The Company's reverse repurchase agreements, repurchase agreements, and other secured borrowings are carried at cost, which approximates fair value due to their short term nature. Reverse repurchase agreements, repurchase agreements, and other secured borrowings are classified as Level 2 based on the adequacy of the collateral and their short term nature. The Senior notes are considered Level 3 liabilities given the relative unobservability of the most significant inputs to valuation estimation as well as the lack of trading activity of these instruments. As of September 30, 2019, the estimated fair value of the Company's Senior notes was based on a third-party valuation.
Schedule of Significant Unobservable Inputs, Qualitative Information | The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of September 30, 2019:
|  | Fair Value |  | Valuation Technique |  | Unobservable Input |  | Range |  | Weighted Average
Description |  |  |  |  | Min |  | Max |
|  | (In thousands) |  |  |  |  |  |  |  |  |  |
Non-Agency RMBS |  | $ | 29,780 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | $ | 13.58 |  |  | $ | 164.58 |  |  | $ | 77.94 |
CMBS |  | 11,240 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 5.75 |  |  | 82.38 |  |  | 66.76 |
CLOs |  | 24,894 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 29.86 |  |  | 298.56 |  |  | 72.29 |
Agency interest only RMBS |  | 3,257 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 3.03 |  |  | 19.27 |  |  | 9.47 |
Total return swaps - asset |  | 235 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 53.50 |  |  | 95.00 |  |  | 88.56 |
Total return swaps - liability |  | (214 | ) |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 53.50 |  |  | 54.50 |  |  | 54.00 |
Corporate debt and equity |  | 2,670 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 97.25 |  |  | 100.50 |  |  | 98.65 |
Corporate loans |  | 5,790 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 100.00 |  |  | 100.00 |  |  | 100.00 |
Non-Agency RMBS |  | 51,702 |  |  | Discounted Cash Flows |  | Yield |  | 3.5 | % |  | 57.8 | % |  | 13.8 | %
|  |  |  |  |  | Projected Collateral Prepayments |  | 29.7 | % |  | 72.0 | % |  | 58.5 | %
|  |  |  |  |  | Projected Collateral Losses |  | 0.2 | % |  | 11.7 | % |  | 4.8 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 0.0 | % |  | 22.4 | % |  | 7.6 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 16.3 | % |  | 52.2 | % |  | 29.1 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Non-Agency CMBS |  | 1,128 |  |  | Discounted Cash Flows |  | Yield |  | 25.0 | % |  | 25.0 | % |  | 25.0 | %
|  |  |  |  |  | Projected Collateral Losses |  | 1.0 | % |  | 1.0 | % |  | 1.0 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 3.1 | % |  | 3.1 | % |  | 3.1 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 95.9 | % |  | 95.9 | % |  | 95.9 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Corporate debt and equity |  | 2,790 |  |  | Discounted Cash Flows |  | Yield |  | 10.0 | % |  | 10.0 | % |  | 10.0 | %
CLOs |  | 3,114 |  |  | Discounted Cash Flows |  | Yield |  | 15.7 | % |  | 24.0 | % |  | 19.6 | %
|  |  |  |  |  | Projected Collateral Prepayments |  | 78.2 | % |  | 83.0 | % |  | 80.5 | %
|  |  |  |  |  | Projected Collateral Losses |  | 10.4 | % |  | 15.6 | % |  | 14.0 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 4.5 | % |  | 6.2 | % |  | 5.5 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
ABS backed by consumer loans |  | 39,316 |  |  | Discounted Cash Flows |  | Yield |  | 12.0 | % |  | 24.5 | % |  | 12.2 | %
|  |  |  |  |  | Projected Collateral Prepayments |  | 0.0 | % |  | 11.4 | % |  | 9.5 | %
|  |  |  |  |  | Projected Collateral Losses |  | 0.9 | % |  | 48.0 | % |  | 14.2 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 52.0 | % |  | 98.7 | % |  | 76.3 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
(continued) |  | Fair Value |  | Valuation Technique |  | Unobservable Input |  | Range |  | Weighted Average
Description |  |  |  |  | Min |  | Max |
|  | (In thousands) |  |  |  |  |  |  |  |  |  |
Consumer loans |  | $ | 151,699 |  |  | Discounted Cash Flows |  | Yield |  | 7.0 | % |  | 10.0 | % |  | 8.1 | %
|  |  |  |  |  | Projected Collateral Prepayments |  | 0.0 | % |  | 43.9 | % |  | 15.3 | %
|  |  |  |  |  | Projected Collateral Losses |  | 3.3 | % |  | 86.4 | % |  | 8.2 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 13.6 | % |  | 87.2 | % |  | 76.5 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Corporate loans |  | 10,000 |  |  | Discounted Cash Flows |  | Yield |  | 15.0 | % |  | 18.0 | % |  | 16.5 | %
Performing commercial mortgage loans |  | 222,219 |  |  | Discounted Cash Flows |  | Yield |  | 8.0 | % |  | 12.6 | % |  | 8.9 | %
Non-performing commercial mortgage loans |  | 38,407 |  |  | Discounted Cash Flows |  | Yield |  | 10.3 | % |  | 16.2 | % |  | 11.2 | %
|  |  |  |  |  | Months to Resolution |  | 1.0 |  |  | 5.0 |  |  | 2.5 |
Performing and re-performing residential mortgage loans |  | 316,804 |  |  | Discounted Cash Flows |  | Yield |  | 3.3 | % |  | 58.1 | % |  | 5.6 | %
Securitized residential mortgage loans(1)(2) |  | 466,297 |  |  | Discounted Cash Flows |  | Yield |  | 3.6 | % |  | 10.0 | % |  | 4.9 | %
Non-performing residential mortgage loans |  | 14,628 |  |  | Discounted Cash Flows |  | Yield |  | 1.4 | % |  | 37.6 | % |  | 10.4 | %
|  |  |  |  |  | Months to Resolution |  | 0.0 |  |  | 115.8 |  |  | 53.9 |
Credit default swaps on asset-backed securities |  | 1,078 |  |  | Net Discounted Cash Flows |  | Projected Collateral Prepayments |  | 33.7 | % |  | 40.2 | % |  | 35.5 | %
|  |  |  |  |  | Projected Collateral Losses |  | 10.8 | % |  | 15.7 | % |  | 11.8 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 15.2 | % |  | 19.9 | % |  | 18.5 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 30.7 | % |  | 35.6 | % |  | 34.2 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Agency interest only RMBS |  | 20,242 |  |  | Option Adjusted Spread ("OAS") |  | LIBOR OAS(3) |  | 93 |  |  | 3,527 |  |  | 953 |
|  |  |  |  |  | Projected Collateral Prepayments |  | 13.3 | % |  | 100.0 | % |  | 80.4 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 0.0 | % |  | 86.7 | % |  | 19.6 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Investment in unconsolidated entities |  | 34,715 |  |  | Enterprise Value |  | Equity Price-to-Book(4) |  | 1.0x |  | 2.5x |  | 1.3x
Investment in unconsolidated entities |  | 3,000 |  |  | Recent Transactions |  | Transaction Price |  | n/a |  | n/a |  | n/a
Investment in unconsolidated entities |  | 32,720 |  |  | Discounted Cash Flows |  | Yield(5) |  | 4.6% |  | 15.6% |  | 9.7%
Other secured borrowings, at fair value(1) |  | (438,629 | ) |  | Discounted Cash Flows |  | Yield |  | 3.2% |  | 10.0% |  | 4.4%
(1) | Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFE as discussed in Note 2.
(2) | Includes $1.3 million of non-performing securitized residential mortgage loans.
(3) | Shown in basis points.
(4) | Represent an estimation of where market participants might value an enterprise on a price-to-book basis.
(5) | Represents the significant unobservable inputs used to fair value the financial instruments of the unconsolidated entity. The fair value of such financial instruments is the largest component of the valuation of such entity as a whole.
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2018:
|  | Fair Value |  | Valuation Technique |  | Unobservable Input |  | Range |  | Weighted Average
Description |  |  |  |  | Min |  | Max |
|  | (In thousands) |  |  |  |  |  |  |  |  |  |
Private label residential mortgage-backed securities |  | $ | 36,945 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | $ | 17.42 |  |  | $ | 178.00 |  |  | $ | 78.31 |
Collateralized loan obligations |  | 5,828 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 2.64 |  |  | 375.00 |  |  | 167.78 |
Corporate debt, non-exchange traded corporate equity, and secured notes |  | 13,976 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 9.69 |  |  | 91.00 |  |  | 59.18 |
Private label commercial mortgage-backed securities |  | 576 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 5.93 |  |  | 6.36 |  |  | 6.14 |
Agency interest only residential mortgage-backed securities |  | 744 |  |  | Market Quotes |  | Non Binding Third-Party Valuation |  | 1.70 |  |  | 9.12 |  |  | 5.64 |
Private label residential mortgage-backed securities |  | 54,346 |  |  | Discounted Cash Flows |  | Yield |  | 3.5 | % |  | 66.1 | % |  | 10.7 | %
|  |  |  |  |  | Projected Collateral Prepayments |  | 16.0 | % |  | 92.1 | % |  | 50.4 | %
|  |  |  |  |  | Projected Collateral Losses |  | 0.0 | % |  | 23.1 | % |  | 8.7 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 1.5 | % |  | 14.6 | % |  | 7.3 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 6.1 | % |  | 61.8 | % |  | 33.6 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Private label commercial mortgage-backed securities |  | 227 |  |  | Discounted Cash Flows |  | Yield |  | 3.4 | % |  | 3.4 | % |  | 3.4 | %
|  |  |  |  |  | Projected Collateral Losses |  | 2.0 | % |  | 2.0 | % |  | 2.0 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 6.6 | % |  | 6.6 | % |  | 6.6 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 91.4 | % |  | 91.4 | % |  | 91.4 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Corporate debt and non-exchange traded corporate equity |  | 4,793 |  |  | Discounted Cash Flows |  | Yield |  | 17.5 | % |  | 17.5 | % |  | 17.5 | %
(continued) |  | Fair Value |  | Valuation Technique |  | Unobservable Input |  | Range |  | Weighted Average
Description |  |  |  |  | Min |  | Max |
|  | (In thousands) |  |  |  |  |  |  |  |  |  |
Collateralized loan obligations |  | $ | 9,087 |  |  | Discounted Cash Flows |  | Yield |  | 12.6 | % |  | 103.1 | % |  | 26.7 | %
|  |  |  |  |  | Projected Collateral Prepayments |  | 8.1 | % |  | 88.4 | % |  | 65.2 | %
|  |  |  |  |  | Projected Collateral Losses |  | 3.7 | % |  | 40.8 | % |  | 13.5 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 4.2 | % |  | 38.0 | % |  | 11.9 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 3.5 | % |  | 13.5 | % |  | 9.4 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Consumer loans and asset-backed securities backed by consumer loans |  | 206,761 |  |  | Discounted Cash Flows |  | Yield |  | 7.0 | % |  | 18.3 | % |  | 8.5 | %
|  |  |  |  |  | Projected Collateral Prepayments |  | 0.0 | % |  | 45.9 | % |  | 33.5 | %
|  |  |  |  |  | Projected Collateral Losses |  | 2.6 | % |  | 84.8 | % |  | 9.1 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 15.2 | % |  | 96.6 | % |  | 57.4 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Performing commercial mortgage loans |  | 163,876 |  |  | Discounted Cash Flows |  | Yield |  | 8.0 | % |  | 22.5 | % |  | 9.6 | %
Non-performing commercial mortgage loans and commercial real estate owned |  | 80,513 |  |  | Discounted Cash Flows |  | Yield |  | 9.6 | % |  | 27.4 | % |  | 13.2 | %
|  |  |  |  |  | Months to Resolution |  | 3.0 |  |  | 16.0 |  |  | 7.9 |
Performing residential mortgage loans |  | 171,367 |  |  | Discounted Cash Flows |  | Yield |  | 2.7 | % |  | 12.9 | % |  | 6.0 | %
Securitized residential mortgage loans(1) |  | 314,202 |  |  | Discounted Cash Flows |  | Yield |  | 4.3 | % |  | 4.6 | % |  | 4.6 | %
Non-performing residential mortgage loans and residential real estate owned |  | 12,557 |  |  | Discounted Cash Flows |  | Yield |  | 4.3 | % |  | 25.1 | % |  | 11.3 | %
|  |  |  |  |  | Months to Resolution(2) |  | 1.9 |  |  | 42.2 |  |  | 27.8 |
Credit default swaps on asset-backed securities |  | 1,472 |  |  | Net Discounted Cash Flows |  | Projected Collateral Prepayments |  | 33.6 | % |  | 42.0 | % |  | 36.5 | %
|  |  |  |  |  | Projected Collateral Losses |  | 11.1 | % |  | 15.6 | % |  | 12.8 | %
|  |  |  |  |  | Projected Collateral Recoveries |  | 10.3 | % |  | 18.7 | % |  | 15.8 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 32.0 | % |  | 36.5 | % |  | 34.9 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Agency interest only residential mortgage-backed securities |  | 6,549 |  |  | Option Adjusted Spread ("OAS") |  | LIBOR OAS(3) |  | 211 |  |  | 3,521 |  |  | 677 |
|  |  |  |  |  | Projected Collateral Prepayments |  | 37.7 | % |  | 100.0 | % |  | 66.2 | %
|  |  |  |  |  | Projected Collateral Scheduled Amortization |  | 0.0 | % |  | 62.3 | % |  | 33.8 | %
|  |  |  |  |  |  |  |  |  |  |  | 100.0 | %
Non-exchange traded common equity investment in mortgage-related entity |  | 6,750 |  |  | Enterprise Value |  | Equity Price-to-Book(4) |  | 3.3x |  | 3.3x |  | 3.3x
Non-exchange traded preferred equity investment in mortgage-related entity |  | 27,317 |  |  | Enterprise Value |  | Equity Price-to-Book(4) |  | 1.1x |  | 1.1x |  | 1.1x
Non-exchange traded preferred equity investment in loan origination entity |  | 3,000 |  |  | Recent Transactions |  | Transaction Price |  | N/A |  | N/A |  | N/A
Non-controlling equity interest in limited liability company |  | 5,192 |  |  | Discounted Cash Flows |  | Yield(5) |  | 12.9% |  | 16.1% |  | 15.4%
Other secured borrowings, at fair value(1) |  | (297,948 | ) |  | Discounted Cash Flows |  | Yield |  | 3.9% |  | 4.4% |  | 4.3%
(1) | Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFE as discussed in Note 2.
(2) | Excludes certain loans that are re-performing.
(3) | Shown in basis points.
(4) | Represent an estimation of where market participants might value an enterprise on a price-to-book basis.
(5) | Represents the significant unobservable inputs used to fair value the financial instruments of the limited liability company. The fair value of such financial instruments is the largest component of the valuation of the limited liability company as a whole.
Fair Value Measurement Using Significant Unobservable Inputs | The tables below include a roll-forward of the Company's financial instruments for the three- and nine-month periods ended September 30, 2019 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy. Level 3—Fair Value Measurement Using Significant Unobservable Inputs: Three-Month Period Ended September 30, 2019
(In thousands) | Beginning Balance as of June 30, 2019 |  | Accreted Discounts / (Amortized Premiums) |  | Net Realized Gain/ (Loss) |  | Change in Net Unrealized Gain/(Loss) |  | Purchases/ Payments |  | Sales/ Issuances |  | Transfers Into Level 3 |  | Transfers Out of Level 3 |  | Ending Balance as of September 30, 2019
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities, at fair value: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Agency RMBS | $ | 11,034 |  |  | $ | (1,164 | ) |  | $ | (621 | ) |  | $ | 696 |  |  | $ | 13,254 |  |  | $ | — |  |  | $ | 737 |  |  | $ | (437 | ) |  | $ | 23,499 |
Non-Agency RMBS | 96,790 |  |  | (121 | ) |  | 7,836 |  |  | (6,457 | ) |  | 6,483 |  |  | (21,457 | ) |  | 5,808 |  |  | (7,400 | ) |  | 81,482 |
CMBS | 6,278 |  |  | 25 |  |  | 374 |  |  | (302 | ) |  | 6,815 |  |  | (1,474 | ) |  | 652 |  |  | — |  |  | 12,368 |
CLOs | 17,222 |  |  | (184 | ) |  | 1,158 |  |  | 184 |  |  | — |  |  | (1,139 | ) |  | 15,287 |  |  | (4,520 | ) |  | 28,008 |
Asset-backed securities backed by consumer loans | 25,019 |  |  | (611 | ) |  | (100 | ) |  | (320 | ) |  | 18,638 |  |  | (3,310 | ) |  | — |  |  | — |  |  | 39,316 |
Corporate debt securities | 4,081 |  |  | — |  |  | (583 | ) |  | 142 |  |  | 6,425 |  |  | (6,883 | ) |  | — |  |  | — |  |  | 3,182 |
Corporate equity securities | 1,791 |  |  | — |  |  | (768 | ) |  | (61 | ) |  | 1,316 |  |  | — |  |  | — |  |  | — |  |  | 2,278 |
Loans, at fair value: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Residential mortgage loans | 663,880 |  |  | (2,241 | ) |  | (400 | ) |  | 3,559 |  |  | 191,512 |  |  | (58,582 | ) |  | — |  |  | — |  |  | 797,728 |
Commercial mortgage loans | 260,034 |  |  | (52 | ) |  | (1 | ) |  | 507 |  |  | 32,426 |  |  | (32,288 | ) |  | — |  |  | — |  |  | 260,626 |
Consumer loans | 162,609 |  |  | (6,474 | ) |  | (1,055 | ) |  | 28 |  |  | 33,101 |  |  | (36,510 | ) |  | — |  |  | — |  |  | 151,699 |
Corporate loans | 5,000 |  |  | — |  |  | — |  |  | — |  |  | 10,790 |  |  | — |  |  | — |  |  | — |  |  | 15,790 |
Investment in unconsolidated entities, at fair value | 69,676 |  |  | — |  |  | (139 | ) |  | 2,935 |  |  | 9,643 |  |  | (11,680 | ) |  | — |  |  | — |  |  | 70,435 |
Financial derivatives–assets, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities | 1,090 |  |  | — |  |  | 16 |  |  | (12 | ) |  | 10 |  |  | (26 | ) |  | — |  |  | — |  |  | 1,078 |
Total return swaps | 87 |  |  | — |  |  | (15 | ) |  | 148 |  |  | — |  |  | 15 |  |  | — |  |  | — |  |  | 235 |
Total assets, at fair value | $ | 1,324,591 |  |  | $ | (10,822 | ) |  | $ | 5,702 |  |  | $ | 1,047 |  |  | $ | 330,413 |  |  | $ | (173,334 | ) |  | $ | 22,484 |  |  | $ | (12,357 | ) |  | $ | 1,487,724 |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Financial derivatives–assets, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total return swaps | $ | — |  |  | $ | — |  |  | $ | 48 |  |  | $ | (214 | ) |  | $ | — |  |  | $ | (48 | ) |  | $ | — |  |  | $ | — |  |  | $ | (214 | )
Other secured borrowings, at fair value | (475,816 | ) |  | — |  |  | — |  |  | (72 | ) |  | 37,259 |  |  | — |  |  | — |  |  | — |  |  | (438,629 | )
Total liabilities, at fair value | $ | (475,816 | ) |  | $ | — |  |  | $ | 48 |  |  | $ | (286 | ) |  | $ | 37,259 |  |  | $ | (48 | ) |  | $ | — |  |  | $ | — |  |  | $ | (438,843 | )
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Condensed Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2019, as well as Level 3 financial instruments disposed of by the Company during the three-month period ended September 30, 2019. For Level 3 financial instruments held by the Company at September 30, 2019, change in net unrealized gain (loss) of $(4.7) million, $4.1 million, $3.3 million, $0.1 million, $(0.2) million, and $(0.1) million, for the three-month period ended September 30, 2019 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively. At September 30, 2019, the Company transferred $12.4 million of assets from Level 3 to Level 2 and $22.5 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources. Nine-Month Period Ended September 30, 2019
(In thousands) | Beginning Balance as of January 1, 2019 |  | Accreted Discounts / (Amortized Premiums) |  | Net Realized Gain/ (Loss) |  | Change in Net Unrealized Gain/(Loss) |  | Purchases/ Payments |  | Sales/ Issuances |  | Transfers Into Level 3 |  | Transfers Out of Level 3 |  | Ending Balance as of September 30, 2019
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities, at fair value: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Agency RMBS | $ | 7,293 |  |  | $ | (2,228 | ) |  | $ | (1,228 | ) |  | $ | 1,430 |  |  | $ | 14,854 |  |  | $ | (463 | ) |  | $ | 4,708 |  |  | $ | (867 | ) |  | $ | 23,499 |
Non-Agency RMBS | 91,291 |  |  | 104 |  |  | 7,187 |  |  | (4,482 | ) |  | 10,239 |  |  | (27,514 | ) |  | 14,633 |  |  | (9,976 | ) |  | 81,482 |
CMBS | 803 |  |  | (16 | ) |  | 76 |  |  | (73 | ) |  | 7,937 |  |  | (221 | ) |  | 3,862 |  |  | — |  |  | 12,368 |
CLOs | 14,915 |  |  | (670 | ) |  | (536 | ) |  | 1,889 |  |  | 816 |  |  | (1,125 | ) |  | 15,287 |  |  | (2,568 | ) |  | 28,008 |
Asset-backed securities backed by consumer loans | 22,800 |  |  | (1,580 | ) |  | (765 | ) |  | 537 |  |  | 28,189 |  |  | (9,865 | ) |  | — |  |  | — |  |  | 39,316 |
Corporate debt securities | 6,318 |  |  | 22 |  |  | (928 | ) |  | 65 |  |  | 9,257 |  |  | (11,552 | ) |  | — |  |  | — |  |  | 3,182 |
Corporate equity securities | 1,534 |  |  | — |  |  | (910 | ) |  | 337 |  |  | 1,317 |  |  | — |  |  | — |  |  | — |  |  | 2,278 |
Loans, at fair value: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Residential mortgage loans | 496,829 |  |  | (4,515 | ) |  | 1,554 |  |  | 7,717 |  |  | 452,958 |  |  | (156,815 | ) |  | — |  |  | — |  |  | 797,728 |
Commercial mortgage loans | 195,301 |  |  | 1,087 |  |  | 1,412 |  |  | (1,844 | ) |  | 128,839 |  |  | (64,169 | ) |  | — |  |  | — |  |  | 260,626 |
Consumer loans | 183,961 |  |  | (22,432 | ) |  | (4,565 | ) |  | 2,726 |  |  | 103,983 |  |  | (111,974 | ) |  | — |  |  | — |  |  | 151,699 |
Corporate loan | — |  |  | — |  |  | — |  |  | — |  |  | 15,790 |  |  | — |  |  | — |  |  | — |  |  | 15,790 |
Investment in unconsolidated entities, at fair value | 72,298 |  |  | 276 |  |  | 1,545 |  |  | 5,125 |  |  | 40,097 |  |  | (48,906 | ) |  | — |  |  | — |  |  | 70,435 |
Financial derivatives–assets, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities | 1,472 |  |  | — |  |  | 419 |  |  | (394 | ) |  | 18 |  |  | (437 | ) |  | — |  |  | — |  |  | 1,078 |
Total return swaps | — |  |  | — |  |  | 1 |  |  | 235 |  |  | — |  |  | (1 | ) |  | — |  |  | — |  |  | 235 |
Total assets, at fair value | $ | 1,094,815 |  |  | $ | (29,952 | ) |  | $ | 3,262 |  |  | $ | 13,268 |  |  | $ | 814,294 |  |  | $ | (433,042 | ) |  | $ | 38,490 |  |  | $ | (13,411 | ) |  | $ | 1,487,724 |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Financial derivatives–assets, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total return swaps | $ | — |  |  | $ | — |  |  | $ | 48 |  |  | $ | (214 | ) |  | $ | — |  |  | $ | (48 | ) |  | $ | — |  |  | $ | — |  |  | $ | (214 | )
Other secured borrowings, at fair value | (297,948 | ) |  | — |  |  | — |  |  | (32 | ) |  | 78,887 |  |  | (219,536 | ) |  | — |  |  | — |  |  | (438,629 | )
Total liabilities, at fair value | $ | (297,948 | ) |  | $ | — |  |  | $ | 48 |  |  | $ | (246 | ) |  | $ | 78,887 |  |  | $ | (219,584 | ) |  | $ | — |  |  | $ | — |  |  | $ | (438,843 | )
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Condensed Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2019, as well as Level 3 financial instruments disposed of by the Company during the nine-month period ended September 30, 2019. For Level 3 financial instruments held by the Company at September 30, 2019, change in net unrealized gain (loss) of $(0.4) million, $10.2 million, $2.4 million, $(0.2) million, $(0.2) million, and $(32) thousand, for the nine-month period ended September 30, 2019 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively. At September 30, 2019, the Company transferred $13.4 million of assets from Level 3 to Level 2 and $38.5 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources. The tables below include a roll-forward of the Company's financial instruments for the three- and nine-month period ended September 30, 2018 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy. Level 3—Fair Value Measurement Using Significant Unobservable Inputs: Three-Month Period Ended September 30, 2018
(In thousands) | Ending Balance as of June 30, 2018 |  | Accreted Discounts / (Amortized Premiums) |  | Net Realized Gain/ (Loss) |  | Change in Net Unrealized Gain/(Loss) |  | Purchases/ Payments |  | Sales/ Issuances |  | Transfers Into Level 3 |  | Transfers Out of Level 3 |  | Ending Balance as of September 30, 2018
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Agency residential mortgage-backed securities | $ | 5,889 |  |  | $ | (509 | ) |  | $ | (24 | ) |  | $ | (67 | ) |  | $ | 773 |  |  | $ | (209 | ) |  | $ | 3,981 |  |  | $ | (1,055 | ) |  | $ | 8,779 |
Private label residential mortgage-backed securities | 96,396 |  |  | (206 | ) |  | 335 |  |  | (1,181 | ) |  | 48,860 |  |  | (16,726 | ) |  | 3,942 |  |  | (10,146 | ) |  | 121,274 |
Private label commercial mortgage-backed securities | 8,761 |  |  | 4 |  |  | 198 |  |  | 494 |  |  | — |  |  | (2,415 | ) |  | — |  |  | (6,059 | ) |  | 983 |
Commercial mortgage loans | 104,951 |  |  | (300 | ) |  | 252 |  |  | 522 |  |  | 36,571 |  |  | (16,188 | ) |  | — |  |  | — |  |  | 125,808 |
Residential mortgage loans | 293,472 |  |  | (513 | ) |  | 25 |  |  | (400 | ) |  | 117,101 |  |  | (17,225 | ) |  | — |  |  | — |  |  | 392,460 |
Collateralized loan obligations | 6,109 |  |  | 302 |  |  | (25 | ) |  | (491 | ) |  | 24,115 |  |  | (3,183 | ) |  | 2,184 |  |  | — |  |  | 29,011 |
Consumer loans and asset-backed securities backed by consumer loans | 199,254 |  |  | (8,012 | ) |  | 7,555 |  |  | (7,615 | ) |  | 54,503 |  |  | (41,181 | ) |  | — |  |  | — |  |  | 204,504 |
Corporate debt | 8,850 |  |  | 13 |  |  | 87 |  |  | (280 | ) |  | 6,780 |  |  | (7,769 | ) |  | — |  |  | — |  |  | 7,681 |
Secured notes | 11,126 |  |  | 405 |  |  | — |  |  | (466 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | 11,065 |
Real estate owned | 34,339 |  |  | — |  |  | (81 | ) |  | 331 |  |  | 475 |  |  | (120 | ) |  | — |  |  | — |  |  | 34,944 |
Corporate equity investments | 44,768 |  |  | — |  |  | 487 |  |  | (377 | ) |  | — |  |  | (5,723 | ) |  | — |  |  | — |  |  | 39,155 |
Total investments, at fair value | 813,915 |  |  | (8,816 | ) |  | 8,809 |  |  | (9,530 | ) |  | 289,178 |  |  | (110,739 | ) |  | 10,107 |  |  | (17,260 | ) |  | 975,664 |
Financial derivatives–assets, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities | 2,591 |  |  | — |  |  | (986 | ) |  | 1,307 |  |  | 27 |  |  | (1,424 | ) |  | — |  |  | — |  |  | 1,515 |
Total financial derivatives– assets, at fair value | 2,591 |  |  | — |  |  | (986 | ) |  | 1,307 |  |  | 27 |  |  | (1,424 | ) |  | — |  |  | — |  |  | 1,515 |
Total investments and financial derivatives–assets, at fair value | $ | 816,506 |  |  | $ | (8,816 | ) |  | $ | 7,823 |  |  | $ | (8,223 | ) |  | $ | 289,205 |  |  | $ | (112,163 | ) |  | $ | 10,107 |  |  | $ | (17,260 | ) |  | $ | 977,179 |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other secured borrowings, at fair value | $ | (101,100 | ) |  | $ | — |  |  | $ | — |  |  | $ | (358 | ) |  | $ | 11,889 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (89,569 | )
Total other secured borrowings, at fair value | $ | (101,100 | ) |  | $ | — |  |  | $ | — |  |  | $ | (358 | ) |  | $ | 11,889 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (89,569 | )
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2018, as well as Level 3 financial instruments disposed of by the Company during the three-month period ended September 30, 2018. For Level 3 financial instruments held by the Company at September 30, 2018, change in net unrealized gain (loss) of $(2.4) million, $(0.1) million, and $(0.4) million, for the three-month period ended September 30, 2018 relate to investments, financial derivatives–assets, and other secured borrowings, at fair value, respectively. At September 30, 2018, the Company transferred $17.3 million of securities from Level 3 to Level 2 and $10.1 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third party pricing sources. Nine-Month Period Ended September 30, 2018
(In thousands) | Ending Balance as of December 31, 2017 |  | Accreted Discounts / (Amortized Premiums) |  | Net Realized Gain/ (Loss) |  | Change in Net Unrealized Gain/(Loss) |  | Purchases/ Payments |  | Sales/ Issuances |  | Transfers Into Level 3 |  | Transfers Out of Level 3 |  | Ending Balance as of September 30, 2018
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Agency residential mortgage-backed securities | $ | 6,173 |  |  | $ | (1,711 | ) |  | $ | 34 |  |  | $ | 206 |  |  | $ | 2,751 |  |  | $ | (1,166 | ) |  | $ | 3,981 |  |  | $ | (1,489 | ) |  | $ | 8,779 |
Private label residential mortgage-backed securities | 101,297 |  |  | 1 |  |  | 2,836 |  |  | (2,392 | ) |  | 76,816 |  |  | (43,723 | ) |  | 7,139 |  |  | (20,700 | ) |  | 121,274 |
Private label commercial mortgage-backed securities | 12,347 |  |  | (225 | ) |  | 1,815 |  |  | 2,111 |  |  | 1,480 |  |  | (16,305 | ) |  | — |  |  | (240 | ) |  | 983 |
Commercial mortgage loans | 108,301 |  |  | 545 |  |  | 1,135 |  |  | 971 |  |  | 60,691 |  |  | (45,835 | ) |  | — |  |  | — |  |  | 125,808 |
Residential mortgage loans | 182,472 |  |  | (1,692 | ) |  | 608 |  |  | (1,319 | ) |  | 266,925 |  |  | (54,534 | ) |  | — |  |  | — |  |  | 392,460 |
Collateralized loan obligations | 24,911 |  |  | 345 |  |  | 826 |  |  | (991 | ) |  | 47,837 |  |  | (30,309 | ) |  | — |  |  | (13,608 | ) |  | 29,011 |
Consumer loans and asset-backed securities backed by consumer loans | 135,258 |  |  | (20,864 | ) |  | 8,506 |  |  | (30 | ) |  | 179,706 |  |  | (98,072 | ) |  | — |  |  | — |  |  | 204,504 |
Corporate debt | 23,947 |  |  | — |  |  | 235 |  |  | (709 | ) |  | 7,684 |  |  | (16,419 | ) |  | — |  |  | (7,057 | ) |  | 7,681 |
Secured notes | — |  |  | 497 |  |  | — |  |  | (700 | ) |  | 11,268 |  |  | — |  |  | — |  |  | — |  |  | 11,065 |
Real estate owned | 26,277 |  |  | — |  |  | (527 | ) |  | 945 |  |  | 10,045 |  |  | (1,796 | ) |  | — |  |  | — |  |  | 34,944 |
Corporate equity investments | 37,465 |  |  | — |  |  | 1,669 |  |  | 3,948 |  |  | 9,078 |  |  | (13,005 | ) |  | — |  |  | — |  |  | 39,155 |
Total investments, at fair value | 658,448 |  |  | (23,104 | ) |  | 17,137 |  |  | 2,040 |  |  | 674,281 |  |  | (321,164 | ) |  | 11,120 |  |  | (43,094 | ) |  | 975,664 |
Financial derivatives–assets, at fair value- |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Credit default swaps on asset-backed securities | 3,140 |  |  | — |  |  | (739 | ) |  | 759 |  |  | 72 |  |  | (1,717 | ) |  | — |  |  | — |  |  | 1,515 |
Total financial derivatives– assets, at fair value | 3,140 |  |  | — |  |  | (739 | ) |  | 759 |  |  | 72 |  |  | (1,717 | ) |  | — |  |  | — |  |  | 1,515 |
Total investments and financial derivatives–assets, at fair value | $ | 661,588 |  |  | $ | (23,104 | ) |  | $ | 16,398 |  |  | $ | 2,799 |  |  | $ | 674,353 |  |  | $ | (322,881 | ) |  | $ | 11,120 |  |  | $ | (43,094 | ) |  | $ | 977,179 |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other secured borrowings, at fair value | $ | (125,105 | ) |  | $ | — |  |  | $ | — |  |  | $ | 840 |  |  | $ | 34,696 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (89,569 | )
Total other secured borrowings, at fair value | $ | (125,105 | ) |  | $ | — |  |  | $ | — |  |  | $ | 840 |  |  | $ | 34,696 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (89,569 | )
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2018, as well as Level 3 financial instruments disposed of by the Company during the nine-month period ended September 30, 2018. For Level 3 financial instruments held by the Company at September 30, 2018, change in net unrealized gain (loss) of $1.8 million, $(0.6) million, and $0.8 million, for the nine-month period ended September 30, 2018 relate to investments, financial derivatives–assets, and other secured borrowings, at fair value, respectively. At September 30, 2018, the Company transferred $43.1 million of securities from Level 3 to Level 2 and $11.1 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19279-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=109250915&loc=d3e13467-108611 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueByBalanceSheetGroupingTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19190-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration